Patients on chronic hemodialysis therapy are at high risk of disturbances in trace element status due to both the underlying disease and the hemodialysis process itself. Data on iodine and bromine levels in these patients are scarce. Using an ICP-MS analytical procedure, serum iodine and bromine levels were determined in a cohort (n = 57) of end-stage renal disease patients on chronic hemodialysis. The results ...
Patients on chronic hemodialysis therapy are at high risk for disturbed trace element status due to both the underlying disease and the hemodialysis process itself. Data on serum bromine levels in these patients are scarce. Using an ICP-MS analytical procedure, serum bromine levels were determined in a cohort of end-stage renal disease patients on chronic hemodialysis (n=57; 68.9±14.0 years old; male/female rat...